Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
cerebroprotein hydrolysate
- Development stage
- Unknown
- Lead developer
- Shanxi Powerdone
- Modality
- Peptides
- Administration
- Intravenous, Intramuscular
01
Overview
Cerebroprotein hydrolysate is a neurotrophic and neuroprotective agent derived from the enzymatic hydrolysis of porcine brain tissue, resulting in a complex mixture of low-molecular-weight peptides and free amino acids. It is designed to cross the blood-brain barrier to support neuronal survival, enhance neuroplasticity, and protect brain tissue from oxidative stress and excitotoxic damage. Primarily utilized in China and other regions, it is indicated for the treatment of traumatic brain injury, cerebrovascular diseases such as ischemic stroke, and cognitive dysfunction following neurosurgery. ShanXi PuDe Pharmaceutical is a key manufacturer of the "Cerebroprotein Hydrolysate III for Injection" formulation, which is approved by the NMPA for clinical use.
- Brand names
- Cogny
- Other names
- 脑蛋白水解物Cerebroprotein Hydrolysate IIICerebroprotein HydrolysateCerebroprotein Hydrolysate III for Injection注射用脑蛋白水解物III
02
Targets
GPX4 (Glutathione peroxidase 4)NTRK2 (Tropomyosin-related kinase receptor type B)
Beyond the preview
Go deeper on cerebroprotein hydrolysate.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on cerebroprotein hydrolysate.